Transcatheter heart valves technologies

Transcatheter heart valves technologies

Abstract Background Bleeding and stroke are frequent complications after transcatheter aortic valve implantation (TAVI). The mortality risk associated with these

Read More

Transcatheter heart valves technologies

Read More

Transcatheter heart valves technologies

Abstract Background Acute intraoperative hypercapnia and respiratory acidosis, which can occur during monitored anaesthesia care (MAC), pose significant cardiopulmonary risks

Read More

Transcatheter heart valves technologies

Abstract Background Paravalvular leakage (PVL) and conduction disorders that require permanent pacemaker implantation (PPI) remain clinically relevant challenges after transcatheter

Read More

Transcatheter heart valves technologies

Abstract Background Older adults with severe aortic stenosis (AS) may receive care in a nursing home (NH) prior to undergoing

Read More

Transcatheter heart valves technologies

Abstract Background In 2019, the US Food and Drug Administration (FDA) approved transcatheter aortic valve replacement (TAVR) for low‐risk patients

Read More

Transcatheter heart valves technologies

Abstract Aims We aimed to evaluate transcatheter mitral valve implantation (TMVI) using predominantly balloon‐expandable transcatheter heart valves (THV) in patients

Read More

Transcatheter heart valves technologies

Abstract Background Elevated aortic valve gradients are common after transcatheter aortic valve implantation for degenerated surgical aortic valve replacement bioprostheses,

Read More

Transcatheter heart valves technologies

Abstract Background Mitral regurgitation (MR) is frequent in patients with aortic stenosis (AS). Although primary MR is an established negative

Read More

Transcatheter heart valves technologies

Abstract More than mild paravalvular leak (PVL) following transcatheter aortic valve implantation (TAVI) is associated with a twofold increase in

Read More

1 2 3 4 5 6 16